scanX
Home
Megasoft

Megasoft

67.51
-2.33
(-3.34%)
Market Cap (₹ Cr.)
₹518
52 Week High
107.25
Book Value
₹
52 Week Low
47.00
PE Ratio
PB Ratio
4.25
PE for Sector
37.21
PB for Sector
3.95
ROE
%
ROCE
7.44 %
Dividend Yield
0.00 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-14.69 %
Net Income Growth
-33.30 %
Cash Flow Change
173.93 %
ROE
-28.59 %
ROCE
17.32 %
EBITDA Margin (Avg.)
38.14 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
11
8
8
7
9
7
16
13
3
5
3
15
7
5
4
2
23
5
6
7
8
6
5
5
7
8
9
8
20
11
11
11
11
11
11
8
8
8
9
Expenses
10
7
7
6
8
6
8
14
8
6
6
13
6
5
6
5
14
4
4
5
7
3
3
4
6
4
6
5
17
7
6
3
3
3
2
2
1
2
2
EBITDA
1
1
1
1
1
1
8
-1
-4
-1
-3
1
1
0
-1
-3
9
2
2
2
2
3
2
2
1
4
2
3
3
4
5
8
8
9
8
5
6
6
6
Operating Profit %
1 %
9 %
8 %
6 %
9 %
14 %
7 %
-11 %
-106 %
-40 %
-96 %
8 %
12 %
-37 %
-85 %
-172 %
10 %
20 %
-0 %
6 %
-0 %
26 %
15 %
11 %
-38 %
-3 %
-68 %
-28 %
-586 %
-272 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
1
1
1
1
0
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
1
1
2
4
4
4
4
4
5
4
4
Profit Before Tax
-0
0
0
-0
1
0
8
-2
-5
-2
-4
0
0
-1
-2
-4
8
0
0
0
-0
1
0
0
-0
2
1
2
1
2
2
4
3
4
4
0
0
1
1
Tax
-0
-0
0
-0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
Net Profit
0
0
0
-0
0
0
8
-2
-5
-2
-4
0
0
-1
-2
-4
7
0
0
0
-0
1
0
0
-0
2
1
2
1
2
2
4
3
3
3
0
0
1
1
EPS in ₹
0.06
0.06
0.03
0.00
0.00
0.06
1.71
-0.47
-1.18
-0.55
-0.82
0.10
0.02
-0.13
-0.52
-0.88
1.63
0.05
0.02
0.07
-0.02
0.24
0.07
0.02
-0.02
0.52
0.58
0.20
0.08
0.28
0.31
0.53
0.44
0.44
0.46
0.06
0.06
0.07
0.12
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
210
182
228
253
287
291
278
256
380
389
Fixed Assets
47
61
55
13
105
135
138
185
179
187
Current Assets
94
65
116
59
52
57
41
63
53
53
Capital Work in Progress
0
0
0
58
31
0
0
0
0
0
Investments
0
0
56
56
34
34
34
7
136
136
Other Assets
162
121
117
126
117
122
107
65
64
66
Total Liabilities
35
37
82
111
139
142
129
72
184
185
Current Liabilities
34
35
71
101
127
127
108
24
23
26
Non Current Liabilities
1
2
10
10
12
16
21
48
160
159
Total Equity
174
145
146
142
148
148
150
185
196
204
Reserve & Surplus
130
101
102
97
103
104
105
111
122
130
Share Capital
44
44
44
44
44
44
44
74
74
74
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-3
0
-2
-0
1
-1
0
32
-30
15
Investing Activities
-1
-3
-2
-16
-39
-1
-1
-42
-147
10
Operating Activities
1
6
3
18
48
7
11
23
13
23
Financing Activities
-3
-2
-2
-2
-9
-7
-10
51
103
-17
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
42.55 %
43.77 %
43.77 %
43.77 %
43.77 %
43.77 %
43.77 %
43.77 %
43.77 %
43.54 %
42.77 %
35.07 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.07 %
0.14 %
DIIs
8.57 %
8.57 %
0.04 %
0.04 %
0.04 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.12 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
91.43 %
91.43 %
99.96 %
99.96 %
57.41 %
56.23 %
56.23 %
56.23 %
56.23 %
56.23 %
56.23 %
56.23 %
56.11 %
56.41 %
57.16 %
64.79 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,772.55 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,461.75 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,526.50 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,194.15 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
943.70 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,038.65 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,219.95 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,591.55 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,462.70 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,569.90 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
49.33
ATR(14)
Less Volatile
3.74
STOCH(9,6)
Neutral
30.84
STOCH RSI(14)
Oversold
6.45
MACD(12,26)
Bearish
-0.69
ADX(14)
Weak Trend
16.42
UO(9)
Bearish
43.44
ROC(12)
Uptrend And Accelerating
4.79
WillR(14)
Neutral
-70.35
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.